-
1
المؤلفون: Gooitzen M. van Dam, Evert van den Broek, Yang Hang Tang, Bert van der Vegt, W. T. R. Hooghiemstra, Jan J. Doff, Kees-Pieter Schepman, Jasper Vonk, Sebastiaan A. H. J. de Visscher, Matthijs D. Linssen, Max J. H. Witjes, F. J. Voskuil, Jaron Gérard de Wit
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Microbes in Health and Disease (MHD), Targeted Gynaecologic Oncology (TARGON)
المصدر: Journal of Nuclear Medicine, 63(5), 672-678. SOC NUCLEAR MEDICINE INC
مصطلحات موضوعية: medicine.medical_specialty, PET/CT, EGFR, Cetuximab, fluorescence molecular imaging, cetuximab-800CW, Metastasis, NECK-CANCER, medicine, Humans, Radiology, Nuclear Medicine and imaging, HEAD, Stage (cooking), Lymph node, Retrospective Studies, integumentary system, lymph node metastasis, business.industry, Head and neck cancer, Cancer, medicine.disease, Primary tumor, Molecular Imaging, ErbB Receptors, medicine.anatomical_structure, VISION, Head and Neck Neoplasms, Lymphatic Metastasis, Carcinoma, Squamous Cell, Resection margin, Lymph Node Excision, Mouth Neoplasms, head and neck cancer, Lymph Nodes, Radiology, business, epidermal growth factor receptor, BURDEN, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b34bb0c6db62f0491f072a9f20a9f9Test
https://doi.org/10.2967/jnumed.121.262530Test -
2
المؤلفون: T. Jeroen N. Hiltermann, Elisabeth Brouwer, Kornelis S M van der Geest, Abraham Rutgers, Riemer H. J. A. Slart, Sjoukje F. Oosting, Maria Sandovici
المساهمون: Translational Immunology Groningen (TRIGR), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Cardiovascular Centre (CVC), Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI)
المصدر: Annals of the Rheumatic Diseases, 81:e263. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseasesمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Immunology, Giant Cell Arteritis, medicine.disease_cause, General Biochemistry, Genetics and Molecular Biology, Autoimmunity, Polymyalgia rheumatica, 03 medical and health sciences, 0302 clinical medicine, Stable Disease, Rheumatology, Internal medicine, Immunology and Allergy, Medicine, Humans, Adverse effect, Immune Checkpoint Inhibitors, Glucocorticoids, 030203 arthritis & rheumatology, treatment, business.industry, autoimmunity, Cancer, multidisciplinary team care, Recommendation, medicine.disease, Radiation therapy, 030104 developmental biology, arthritis, Polymyalgia Rheumatica, inflammation, Prednisolone, business, hormones, hormone substitutes, and hormone antagonists, Glucocorticoid, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed5c9553acf540b8346d438106fe6992Test
https://doi.org/10.1136/annrheumdis-2020-218276Test -
3
المؤلفون: John B. A. G. Haanen, Maureen J.B. Aarts, Michel W.J.M. Wouters, Albert J. ten Tije, Astrid A M van der Veldt, Karijn P M Suijkerbuijk, Rozemarijn S. van Rijn, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Ellen Kapiteijn, Geke A. P. Hospers, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Gerard Vreugdenhil, Michiel C T van Zeijl, Jan-Willem B de Groot, Djura Piersma
المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)
المصدر: International Journal of Cancer, 150(2), 317-326. Wiley-Liss Inc.
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800Testمصطلحات موضوعية: Male, advanced melanoma, Cancer Research, medicine.medical_specialty, real-world, Skin Neoplasms, Programmed Cell Death 1 Receptor, Ipilimumab, Pembrolizumab, Stable Disease, SDG 3 - Good Health and Well-being, Internal medicine, Medicine, Humans, METASTATIC MELANOMA, Adverse effect, PEMBROLIZUMAB, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, business.industry, Proportional hazards model, IPILIMUMAB, Hazard ratio, Middle Aged, medicine.disease, Prognosis, Discontinuation, Survival Rate, Oncology, Withholding Treatment, SURVIVAL, anti-PD-1, Female, immunotherapy, business, Progressive disease, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Follow-Up Studies, discontinuation
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aecc11f2696429a42f3b7afc5d49f75Test
https://hdl.handle.net/11370/0e72933b-593e-414f-b5ab-c29ab695a795Test -
4
المؤلفون: Walter J.F.M. van der Velden, Anton F.J. de Haan, Nicole M. A. Blijlevens, Suzanne van Dorp, Jürgen Kuball, Moniek de Witte, Goda Choi, Arnold van der Meer, Gerwin Huls
المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Bone Marrow Transplantation, 56, 2651-2655
Bone Marrow Transplantation, 56, 11, pp. 2651-2655
Bone Marrow Transplantation
Bone marrow transplantation, 56(11), 2651-2655. Nature Publishing Groupمصطلحات موضوعية: Oncology, medicine.medical_specialty, Transplantation Conditioning, Graft vs Host Disease, Human leukocyte antigen, Disease, SIROLIMUS, Article, Phase II trials, HEMATOPOIETIC-CELL TRANSPLANTATION, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], immune system diseases, Internal medicine, VERSUS-HOST-DISEASE, medicine, Humans, Transplantation, Homologous, Cumulative incidence, INDEX, Antilymphocyte Serum, Retrospective Studies, Transplantation, business.industry, Incidence (epidemiology), Stem-cell therapies, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Mycophenolic Acid, Anti-thymocyte globulin, surgical procedures, operative, Sirolimus, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Gvhd prophylaxis, business, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdb5d348d8914ced8e098a4ee86200bTest
https://doi.org/10.1038/s41409-021-01369-9Test -
5
المؤلفون: Ina M. Jürgenliemk-Schulz, Elsbieta M. van der Steen-Banasik, Remi A. Nout, Jannet C. Beukema, Max Peters, Baukelien van Triest, Petronella O. Witteveen, Carien L. Creutzberg, Joanne A. de Hullu, Ludy C.H.W. Lutgens, Jacobus van der Velden, Henrike Westerveld, Marnix J.A. Rasing, An Snyers
المساهمون: Radiotherapy, Obstetrics and Gynaecology, CCA -Cancer Center Amsterdam, CCA - Cancer Treatment and Quality of Life, Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Gynecologic Oncology, 163(1), 117-124. Academic Press
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCEمصطلحات موضوعية: Adult, medicine.medical_specialty, CARCINOMA, Osteoradionecrosis, MODULATED RADIATION-THERAPY, medicine.medical_treatment, EUROPEAN-ORGANIZATION, Phases of clinical research, ORAL FLUOROPYRIMIDINE CARBAMATE, PREOPERATIVE CHEMORADIATION, Definitive chemoradiotherapy, Gastroenterology, Capecitabine, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, QUALITY-OF-LIFE, Internal medicine, medicine, Humans, Prospective Studies, Progression-free survival, Aged, Aged, 80 and over, Salvage Therapy, Chemotherapy, Toxicity, Vulvar cancer, Vulvar Neoplasms, business.industry, Obstetrics and Gynecology, Chemoradiotherapy, CHEMOTHERAPY, Middle Aged, medicine.disease, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Radiation therapy, TOXICITY CRITERIA, Oncology, Carcinoma, Squamous Cell, Locally advanced, Female, Organ-sparing, business, RADIOTHERAPY, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6318faf3a3bda95644be767cdfe0c37eTest
https://doi.org/10.1016/j.ygyno.2021.07.020Test -
6
المؤلفون: Robert Peric, Vincent van der Noort, Harry J.M. Groen, Anne-Marie C. Dingemans, Nico van Walree, Franz M.N.H. Schramel, Christi M.J. Steendam, Pepijn Brocken, Stijn L.W. Koolen, G.D. Marijn Veerman, John W. G. van Putten, Ron H.J. Mathijssen, Egbert F. Smit, Joachim G.J.V. Aerts, Magdolen Youssef
المساهمون: Pulmonary Medicine, Medical Oncology, Pharmacy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
المصدر: Lung Cancer, 160, 44-49. Elsevier Ireland Ltd
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTDمصطلحات موضوعية: Pulmonary and Respiratory Medicine, Erlotinib Hydrochloride/therapeutic use, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Combination therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Quinazolines/therapeutic use, Taxoids/therapeutic use, EGFR, Non-Small-Cell Lung/drug therapy, Docetaxel, Gastroenterology, Disease-Free Survival, Erlotinib Hydrochloride, SDG 3 - Good Health and Well-being, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Progression-free survival, Epidermal growth factor receptor, CANCER PATIENTS, Lung Neoplasms/drug therapy, COMBINATION, neoplasms, SCHEDULE, Docetaxel/therapeutic use, biology, PLASMA, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Hazard ratio, CHEMOTHERAPY, medicine.disease, Oncology, Erlotinib, Toxicity, biology.protein, Quinazolines, Taxoids, business, Non-small-cell lung cancer, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1412cde3a5dc0bde1bb210d253e089Test
https://doi.org/10.1016/j.lungcan.2021.08.002Test -
7
المؤلفون: Martijn van Faassen, Marina A. J. Tijssen, Ingrid H. Hof, Tom J. de Koning, Anouk Kuiper, Ido P. Kema, Elze R. Timmers, Marenka Smit, K. E. Niezen-Koning
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Movement Disorder (MD), Center for Liver, Digestive and Metabolic Diseases (CLDM)
المصدر: Parkinsonism & Related Disorders, 91, 48-54. Elsevier
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Levodopa, Serotonin, Adolescent, Dopamine, Motor Activity, Serotonergic, Young Adult, Internal medicine, otorhinolaryngologic diseases, Medicine, Humans, Cervical dystonia, Child, Torticollis, Aged, Dystonia, Aged, 80 and over, business.industry, Dopaminergic, Middle Aged, medicine.disease, nervous system diseases, Endocrinology, Monoamine neurotransmitter, Neurology, Dystonic Disorders, Case-Control Studies, Female, Neurology (clinical), Geriatrics and Gerontology, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b64749edbe29e17b4d0bdc5f2eff52Test
https://doi.org/10.1016/j.parkreldis.2021.08.019Test -
8
المؤلفون: Adriaan A. Lammertsma, Inês Antunes, Alexander Dömling, Philip H. Elsinga, Gonçalo S Clemente, Aren van Waarde, Jurgen W. A. Sijbesma
المساهمون: Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Drug Design, Medicinal Chemistry and Bioanalysis (MCB), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Molecular Neuroscience and Ageing Research (MOLAR)
المصدر: Molecular pharmaceutics, 18(9), 3378-3386. AMER CHEMICAL SOC INC
Molecular Pharmaceuticsمصطلحات موضوعية: Male, Biodistribution, Fluorine Radioisotopes, PHARMACOKINETICS, SEXUAL DIMORPHISM, Atorvastatin, POSITRON EMISSION TOMOGRAPHY, Pharmaceutical Science, Standardized uptake value, Pharmacology, ATORVASTATIN, Article, Sex Factors, Pharmacokinetics, Drug Discovery, medicine, Animals, Tissue Distribution, positron emission tomography (PET), Rats, Wistar, Chemistry, Small intestine, Molecular Imaging, Rats, Hepatobiliary Elimination, medicine.anatomical_structure, Positron-Emission Tomography, fluorine-18, Molecular Medicine, Arterial blood, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Radiopharmaceuticals, Ex vivo, Blood sampling, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abefbcf2269205a14a3325b53a0c871Test
https://hdl.handle.net/11370/512fffc9-2b2f-4588-9b22-df8166c7a78fTest -
9
المؤلفون: Douwe F. Samplonius, Igle J. de Jong, Philip H. Elsinga, Erik F. J. de Vries, Inês Antunes, Wijnand Helfrich, Rutger J. Dost, Rudi Dierckx, Hilde D. Hoving, Aren van Waarde
المساهمون: Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Molecular Neuroscience and Ageing Research (MOLAR), Translational Immunology Groningen (TRIGR), Targeted Gynaecologic Oncology (TARGON)
المصدر: Journal of Nuclear Medicine, 62(2), 1140-1145. SOC NUCLEAR MEDICINE INC
مصطلحات موضوعية: Biodistribution, RESISTANT PROSTATE-CANCER, mice, enzalutamide, PET imaging, Pharmacology, medicine.disease, prostate cancer, Androgen receptor, chemistry.chemical_compound, Prostate cancer, androgen receptors, chemistry, ANTAGONISTS, In vivo, Dihydrotestosterone, LNCaP, medicine, Enzalutamide, Radiology, Nuclear Medicine and imaging, Ex vivo, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::700fd136dde1b767f339320b1ae6afd5Test
https://hdl.handle.net/11370/124cc30d-1282-49b2-8419-5d3af3407b4cTest -
10
المؤلفون: Arjen J. Witkamp, Joost Nederend, Andreas J A Bremers, Philip R. de Reuver, Wilhelmina M U van Grevenstein, Henk M.W. Verheul, Koen P. Rovers, Max J. Lahaye, Niels F. M. Kok, Jurriaan B. Tuynman, Checca Bakkers, Maartje Los, Ignace H. J. T. de Hingh, Anna M.J. Thijs, Patrick H. J. Hemmer, Alexandra R. M. Brandt-Kerkhof, Miriam Koopman, Onno Kranenburg, Petur Snaebjornsson, Marcel G. W. Dijkgraaf, Simon W. Nienhuijs, Arend G. J. Aalbers, Schelto Kruijff, Jacobus W. A. Burger, Tineke E. Buffart, Derk Jan A. de Groot, Esther van Meerten, Iris van 't Erve, Geert-Jan Creemers, Miranda Kusters, Pieter J. Tanis, Eva V. E. Madsen, Remond J.A. Fijneman, Kathelijn S. Versteeg, Djamila Boerma, Cornelis J A Punt, Marinus J. Wiezer
المساهمون: Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, VU University medical center, Epidemiology and Data Science, APH - Methodology, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642Test
JAMA Surgery, 156(8), 710-720. American Medical Association
JAMA surgery, 156(8), 710-720. American Medical Association
JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
JAMA Surgery, 156, 710-720
JAMA Surg
JAMA Surgery, 156, 8, pp. 710-720مصطلحات موضوعية: Male, PROGNOSIS, medicine.medical_treatment, CARCINOMATOSIS, MULTICENTER, Hyperthermic Intraperitoneal Chemotherapy, 030230 surgery, Peritoneal Neoplasms/secondary, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Randomized controlled trial, law, Adenocarcinoma/secondary, Adjuvant/adverse effects, Neoadjuvant therapy, Original Investigation, Bevacizumab/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, CANCER, Neoadjuvant Therapy, Fluorouracil/administration & dosage, Capecitabine/administration & dosage, 030220 oncology & carcinogenesis, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, medicine.drug, medicine.medical_specialty, Camptothecin/administration & dosage, Capecitabine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, REGRESSION, medicine, MANAGEMENT, Chemotherapy, Humans, Organoplatinum Compounds/administration & dosage, Perioperative Period, Response Evaluation Criteria in Solid Tumors, Aged, Colorectal Neoplasms/pathology, HIPEC, business.industry, Perioperative, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Irinotecan, Mitomycin/administration & dosage, Feasibility Studies, business, CONSENSUS
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375b682e7bd1c0c6ebfa96df3e48e33eTest
https://hdl.handle.net/11370/c9e531bb-9f62-460d-afc2-636baf20eec6Test